Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Med Okayama)
Source: Acta Med Okayama - February 29, 2024 Category: Universities & Medical Training Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
Long-Term Follow-up Data of a Multi-Institutional Phase-2 Study of S-1/oxaliplatin and Bevacizumab Therapy in Patients with Advanced Colorectal Cancer: The HiSCO-02 Study
In conclusion, we report here the final prognostic update of the Phase II clinical trial examining the efficacy of SOX plus bevacizumab therapy, the results of which confirm the clinical efficacy of this regimen.PMID:38419314 | DOI:10.18926/AMO/66670 (Source: Acta Medica Okayama)
Source: Acta Medica Okayama - February 29, 2024 Category: General Medicine Authors: Manabu Shimomura Katsunori Shinozaki Takuya Yano Shintaro Akabane Hideki Ohdan Hiroshima Surgical study group of Clinical Oncology (HiSCO) Source Type: research
